| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/09/2000 | EP1024810A1 Method for optimizing retinal and optic nerve health |
| 08/09/2000 | EP1024809A1 Use of immunomodulating agents |
| 08/09/2000 | EP1024808A1 Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application |
| 08/09/2000 | EP1024807A1 Use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an anti-inflammatory drug with prevention of gastric hypersecretion and renal impairment |
| 08/09/2000 | EP1024806A1 Use of non-immunosuppressive compounds for promoting nerve regeneration |
| 08/09/2000 | EP1024805A1 Use of coumarin derivatives for the treatment of digestive tract disorders |
| 08/09/2000 | EP1024804A1 Mtp inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels |
| 08/09/2000 | EP1024803A1 Flavonoids for cystic fibrosis therapy |
| 08/09/2000 | EP1024802A1 (3$i(R),4$i(R))-$g(D)-TETRAHYDROCANNABINOL-11-OIC ACIDS USEFUL AS ANTIINFLAMMATORY AGENTS AND ANALGESICS |
| 08/09/2000 | EP1024801A2 Method for regulating size and growth of vascularized normal tissue |
| 08/09/2000 | EP1024800A1 Thyroxine analogues having no significant hormonal activity to treat malignant tumors |
| 08/09/2000 | EP1024799A1 Method for treating disease-related or drug-induced dyskinesias |
| 08/09/2000 | EP1024798A1 Neomycin/disaccharide water solution for enteroclysis in hepatic encephalopathy |
| 08/09/2000 | EP1024794A1 Methods of treating capsules and dry, powdered pharmaceutical formulations |
| 08/09/2000 | EP1024793A1 Osmotic medicament releasing system |
| 08/09/2000 | EP1024792A1 Topical antifungal composition |
| 08/09/2000 | EP1024789A1 Solution for peritoneal dialysis and process for its manufacture |
| 08/09/2000 | EP1024784A1 Beta-d glucan topical composition |
| 08/09/2000 | EP1024709A1 Organ specific nutrition |
| 08/09/2000 | EP1024697A1 Method for treating alzheimer's disease |
| 08/09/2000 | EP1024696A1 Combination therapy for reducing the risks associated with cardio- and cerebrovascular disease |
| 08/09/2000 | EP1006964A4 Intrauterine chemical necrosing method, composition, and apparatus |
| 08/09/2000 | EP0862563B1 10-deacetyl-14beta-hydroxybaccatine iii derivatives, a process for the preparation thereof and formulations containing them |
| 08/09/2000 | EP0825851A4 Emulsion suitable for administering a poorly water-soluble photosensitizing compound and use thereof |
| 08/09/2000 | EP0820434B1 Phenoxyethylamine derivatives having high affinity for the 5-ht 1a receptor, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing said derivatives |
| 08/09/2000 | EP0799024B1 Pharmaceutical aerosol containing at least one sugar |
| 08/09/2000 | EP0789777B1 Polysaccharides having a high iduronic acid content |
| 08/09/2000 | EP0764159B1 C -4 amide substituted compounds and their use as therapeutic agents |
| 08/09/2000 | EP0734384B1 3-substituted 1-arylindole compounds |
| 08/09/2000 | EP0642519B1 Sulfur-containing phosponate compounds for treating abnormal calcium and phosphate metabolism |
| 08/09/2000 | EP0642513B1 Indolocarbazole imides and their use |
| 08/09/2000 | EP0641201B1 Renewal of extrinsic aging of the skin by transdermal application of selenoamino acids |
| 08/09/2000 | EP0623132B1 Disubstituted polycyclic systems as cognition enhancers |
| 08/09/2000 | EP0596876B1 Chelator compositions comprising alpha-diamine compounds |
| 08/09/2000 | EP0539380B1 Method for the preparation and purification of a mixture of glycosphingolipids free from contamination by non-conventional viruses |
| 08/09/2000 | EP0533846B1 The ciliary neurotrophic factor receptor |
| 08/09/2000 | CN1262686A Organic compound |
| 08/09/2000 | CN1262684A 2,4,4-trisubstituted-1,3-dioxolane antifungals |
| 08/09/2000 | CN1262683A Soluble prodrugs of paclitaxel |
| 08/09/2000 | CN1262682A Itraconazole with improved solubility, method of preparing same and pharmaceutical composition for oral administration comprising same |
| 08/09/2000 | CN1262681A 4,5-dihydro-[1H]-benz [g] indazole-3-carboxylic acid derivatives |
| 08/09/2000 | CN1262680A 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy |
| 08/09/2000 | CN1262679A IL-5 inhibiting 6-azauracil derivatives |
| 08/09/2000 | CN1262678A Triazole compounds and use thereof as dopamine-D3-ligands |
| 08/09/2000 | CN1262677A Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, noval compounds thereof and their use as chemotherapeutic agents |
| 08/09/2000 | CN1262676A 吡啶衍生物 Pyridine derivatives |
| 08/09/2000 | CN1262675A (+)-Norcisapride useful for 5-HT3 and 5-HT4 mediated disorbers |
| 08/09/2000 | CN1262674A Gatrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 08/09/2000 | CN1262627A Composition |
| 08/09/2000 | CN1262625A Use of lactoferin in treatment of allergen induced disorders |
| 08/09/2000 | CN1262624A Use of colchinol derivatives as vascular damaging agents |
| 08/09/2000 | CN1262623A Prostaglandin derivatives devoid of side-effects for treatment of glaucoma |
| 08/09/2000 | CN1262622A Combination therapy for modulating human sexual response |
| 08/09/2000 | CN1262621A Gastrokinetic bicyclc benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 08/09/2000 | CN1262620A Beta-Alkoxyacrylates against malaria |
| 08/09/2000 | CN1262619A Process for preparing reactive pharmaceutical product for detection of gastrointestinal disorder caused by bacteria |
| 08/09/2000 | CN1262618A NF-KB inhibitors containing as active ingredient phenylmethyl benzoquinone |
| 08/09/2000 | CN1262616A Topical application of combination of benzoyl peroxide and second active ingredient |
| 08/09/2000 | CN1262611A Methods for using compositions containing dichlorophenyl imidazoldioxolan to treat sebcrrheic dermatitis, dandruff, psoriasis, and acne, and compositions thereof |
| 08/09/2000 | CN1262600A Compositions and method for reducing respiratory depression and attendant side effects of mu opioid compounds |
| 08/09/2000 | CN1262272A HIV proteinase inhibitor |
| 08/09/2000 | CN1262267A 20 kinds of modified vitamin D series derivatives, preparing and drug thereof |
| 08/09/2000 | CN1262124A Process for preparing liquid medicine to treat dermatopathy |
| 08/09/2000 | CN1262104A Chinese medicine for treating cervical erosion and its preparing process |
| 08/09/2000 | CN1262101A Silver ion disinfectant and preparing process thereof |
| 08/09/2000 | CN1262099A Albendazole emulsion |
| 08/09/2000 | CN1262098A Drug dropping medicine containing verapamil |
| 08/09/2000 | CN1262097A Compound iron ammonium citrate preparation |
| 08/09/2000 | CN1262095A Antitoxtic freeze-dried powder for injection |
| 08/09/2000 | CN1055292C Anti-hyperplasia and anti-inflammatory pentose monosaccharide derivative and medicinal composition containing same |
| 08/08/2000 | US6101412 Compositions, apparatus and methods for facilitating surgical procedures |
| 08/08/2000 | US6100444 Nucleotide sequences coding prostate gland protein; for the treatment of prostate cancer |
| 08/08/2000 | US6100426 Anti-viral compounds |
| 08/08/2000 | US6100411 Taxoid anti-tumor agents and pharmaceutical compositions thereof |
| 08/08/2000 | US6100409 Hydroxy and polyhydroxy derivatives of coumarin, preparation thereof and antiviral action thereof |
| 08/08/2000 | US6100404 Erythromycin compounds |
| 08/08/2000 | US6100390 Nucleotide sequences coding nematode protein; for the prevention of nematode infection of animals |
| 08/08/2000 | US6100302 Propofol formulation with enhanced microbial characteristics |
| 08/08/2000 | US6100300 A therapeutic treatment of deficient blood supply in exercising muscle |
| 08/08/2000 | US6100299 Tumor necrosis factor inhibitor; anticarcinogenic agents, antiinflammatory agents |
| 08/08/2000 | US6100298 Mixture of drug and n-(4-(carboxypropyl)phenyl-4-phenyl-butyramide for improved oral drug delivery |
| 08/08/2000 | US6100297 Administering antioxidant cardioplegic solution during coronary bypass surgery |
| 08/08/2000 | US6100296 Modulation of inflammation related to columnar epithelia |
| 08/08/2000 | US6100294 For treatment of metabolic, glandular, and bone disorders caused by vitamin deficiency |
| 08/08/2000 | US6100290 Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases |
| 08/08/2000 | US6100289 Indole derivatives |
| 08/08/2000 | US6100287 Materials and methods for enhancing muscle performance and recovery from fatigue |
| 08/08/2000 | US6100286 Methods and formulations for modulating the human sexual response |
| 08/08/2000 | US6100285 Method of solubilizing itraconazole |
| 08/08/2000 | US6100284 Antiallergens |
| 08/08/2000 | US6100283 Prodrug phosphate derivative for poly (adp-ribose) polymerase enzyme inhibitor for administering in conjunction with antitumor drug or radiotherapy |
| 08/08/2000 | US6100282 Thiazole derivatives |
| 08/08/2000 | US6100280 Administering a 1-(bis(fluorophenyl)alkyl)-4-(2-oxy-3-(aryl substituted amino)propyl)piperazine derivative to treat narcotic drug dependency with reduced side effects |
| 08/08/2000 | US6100279 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
| 08/08/2000 | US6100278 N-(arylsulphonyl)amino acid derivatives, process for their preparation and pharmaceutical compositions containing them |
| 08/08/2000 | US6100277 Retroviral protease inhibitor combinations |
| 08/08/2000 | US6100275 8-azabicyclo[3.2.1.]oct-2-ene derivatives, their preparation and use |
| 08/08/2000 | US6100274 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions |
| 08/08/2000 | US6100273 Water soluble camptothecin derivatives |
| 08/08/2000 | US6100272 Tetracyclic spiro compounds as 5HT1B receptor antagonists |